Congratulations to the four MNHS nominated finalists for the 2022 prestigious Eureka Prizes
Four Medicine, Nursing and Health Sciences research projects across the ‘Research and Innovation’ and ‘Leadership’ categories have been named as finalists in the 2022 Australian Museum Eureka Prizes.
The Eureka Prizes honour excellence across the areas of research and innovation, leadership, science engagement and school science, and are presented annually in partnership with some of the country’s leading scientific institutions, government organisations, universities and corporations.
The Monash MNHS finalists shortlisted for the 2022 Australian Museum Eureka Prizes are:
Associate Professor Eric Chow (Monash Central Clinical School), Professor Christopher Fairley, Professor Catriona Bradshaw, Professor Marcus Chen, along with Professor Jane Hocking and Professor Deborah Williamson from The University of Melbourne.
Rapid rises in sexually transmitted infection (STI) and antibiotic resistance are a growing global concern. A research team at Monash University in collaboration with The University of Melbourne has explored new routes of transmission for gonorrhoea, and developed novel interventions and strategies to treat and improve the control of gonorrhoea, chlamydia, syphilis and Mycoplasma genitalium and to optimise antimicrobial stewardship. This includes (1) conducting the first clinical trial to compare the efficacy of azithromycin with doxycycline for rectal chlamydia to inform Australian and international treatment guidelines; (2) investigating new agents for resistant M. genitalium and developing a novel resistance-guided treatment strategy to improve cure of M. genitalium that changed international policy and practice; (3) using genomics to respond to sexually transmitted pathogens; and (4) identify kissing as a risk factor for gonorrhoea transmission and investigating mouthwash as a potential intervention for oropharyngeal gonorrhoea.
Associate Professor James Trauer, School of Public Health and Preventive Medicine
Associate Professor Trauer’s research supports the response to respiratory infectious diseases through modelling evidence-based approaches to the public health control across Australia, our region and the world. From 2020, Associate Professor Trauer’s team pivoted from TB to focus on the devastating COVID-19 pandemic, playing a leading role in the response to the virus in Victoria and across the Asia-Pacific Region. This work supported member states of two World Health Organisation regional offices (Western Pacific and South-East Asia), supporting the COVID-19 response in Malaysia, the Philippines, Sri Lanka, Myanmar, Bangladesh, Bhutan, Indonesia and Vietnam. Prior to 2020, his work focused on modelling for improved tuberculosis control in low-income countries, where it has emerged as the world’s leading infectious killer.
Associate Professor Chris Greening, Monash Biomedicine Discovery Institute
Atmospheric emissions of the potent greenhouse gas methane have doubled through human activities and account for a third of global warming. 80% of the methane emitted into the atmosphere is produced by archaea from sources such as livestock and wetlands, and only 5% is consumed by methane-consuming bacteria, primarily in soils, meaning methane is produced at much higher levels than it is recycled. The research-to-action programs led by microbiologist and biochemist Associate Professor Greening are shifting this balance. Through his high-impact basic research, he has advanced the biochemistry, physiology, and ecology of microbial methane cycling. Notably, he has revealed the microbes and processes that control methane production from numerous sources, uncovered new phylum-level lineages and surprising flexibility of methane-consuming bacteria, and discovered certain bacteria can ‘live on air’ by consuming energy sources such as methane. Through large-scale industrial and government partnerships, he has translated these findings to develop novel strategies to decrease methane emissions from livestock, convert waste gases into animal feed (single-cell protein), and restore polluted ecosystems.
Paul Wood AO, Adjunct Professor in Microbiology, Monash Biomedicine Discovery Institute
Professor Wood is nominated for this award for his vision and leadership to establish the Industry Mentoring and Networking in STEM (IMNIS) program. The idea for the IMNIS programme stemmed from a training program for PhD students called “Project to Product”, which was established alongside Monash’s Associate Professor Jose Garcia-Bustos and Associate Professor Priscilla Johanesen to introduce PhD students to how to translate their science to products and work with industry. IMNIS is now the premier Australian mentoring program for PhD students and early career postdocs in STEM, with over 400 individuals being mentored each year. IMNIS continues to expand and is now a high-profile program within the Australian Academy of Technological Sciences and Engineering (ATSE) and part of the new Elevate program to boost women in STEM. The success of IMNIS is a credit to Professor Wood’s vision, leadership, and tenacity to design and build a mentoring program that would have the scale to make a real impact on the future careers of thousands of young researchers in Australia.
The Eureka Prize winners will be announced on Wednesday 31st August via a live broadcast at 7.15pm AEST. To register visit the Australian Museum website.
About Monash University
Monash University is Australia’s largest university with more than 80,000 students. In the 60 years since its foundation, it has developed a reputation for world-leading high-impact research, quality teaching, and inspiring innovation.
With four campuses in Australia and a presence in Malaysia, China, India, Indonesia and Italy, it is one of the most internationalised Australian universities.
As a leading international medical research university with the largest medical faculty in Australia and integration with leading Australian teaching hospitals, we consistently rank in the top 50 universities worldwide for clinical, pre-clinical and health sciences.